Tolerability and Safety of Topiramate in Chinese Patients with Epilepsy: An Open-Label, Long-Term, Prospective Study

By Lu Yang  

Clinical Drug Investigation, Vol. 27, Iss. 10, 2007-01 ,pp. : 683-690

Adis International

Access to resources Recommend Favorite

Signs and symptoms of ocular surface status in glaucoma patients switched from timolol 0.5% to brinzolamide 1%/timolol 0.5% fixed combination: a 6-month efficacy and tolerability, multicenter, open-label prospective study

By Rossi Gemma Caterina Maria   Tinelli Carmine   Pasinetti Gian Maria   Fusetti Marina   Pallavicini Claudio   Stringa Massimo   Vacchi Sauro   Stringa Francesco   Bianchi Paolo Emilio  

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 5, 2011-04 ,pp. : 685-690

Informa Healthcare

Access to resources Recommend Favorite

Visual Field Loss in Patients with Refractory Partial Epilepsy Treated with Vigabatrin: Final Results from an Open-Label, Observational, Multicentre Study

By Wild John M.  

CNS Drugs, Vol. 23, Iss. 11, 2009-11 ,pp. : 965-982

Adis International

Access to resources Recommend Favorite

Safety and Tolerability of a New Formulation of Pancrelipase Delayed-Release Capsules (CREON®) in Children Under Seven Years of Age with Exocrine Pancreatic Insufficiency due to Cystic Fibrosis: An Open-Label, Multicentre, Single-Treatment-Arm Study

By Graff Gavin R.  

Clinical Drug Investigation, Vol. 30, Iss. 6, 2010-06 ,pp. : 351-364

Adis International

Access to resources Recommend Favorite

Antihypertensive Efficacy of Perindopril 5-10 mg/day in Primary Health Care: An Open-Label, Prospective, Observational Study

By Ionescu Dan-Dominic  

Clinical Drug Investigation, Vol. 29, Iss. 12, 2009-12 ,pp. : 767-776

Adis International

Access to resources Recommend Favorite